Avsar.

Healthcare · Pharmaceuticals

Abbott India Ltd (ABBOTINDIA)

₹25,940.00

Mkt cap
₹55,122 Cr
P/E ratio
34.10
P/B
11.54
Div yield
2.02%
ROE
34.40%
ROCE
44.80%
EPS (TTM)
₹760.70
Book value
₹2,247
52W range
25,180–32,575
Sector
Healthcare

Price history

Previous close

Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India. [1] It was established in 1944. [2]

NSE ABBOTINDIABSE 500488
Health check
Mixed
ValuationFair
ProfitabilityStrong
GrowthModerate
TechnicalsBearish
52-week range
−20.37% from high
₹25,940
₹25,180+3.02% from low₹32,575
Current
₹25,940.00
Prev close
₹26,065.00
Day
−0.48%
Price performance
1D
−0.61%
1W
+0.21%
1M
−6.93%
3M
−0.77%
6M
−6.90%
1Y
−19.37%
YTD
−7.77%

Financials

Revenue, profit & margin
P/E ratio
34.1×
ABBOTINDIA is 3% below the sector median of 35.2×
ABBOTINDIA34.1×
Sector median35.2×
 Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Trend
Sales1,4791,4941,4371,4391,5581,6331,6141,6051,7381,7571,7241,7101,814
Expenses1,1241,1131,0491,1091,1671,1941,1781,1761,2931,2551,2611,2291,291
Operating Profit355381388330391439436429446502463481522
OPM %24%25%27%23%25%27%27%27%26%29%27%28%29%
Other Income56565681676072767370707675
Interest3333322468566
Depreciation17181818181818181919191920
Profit before tax390415422390437479488483493546509531572
Tax %26%25%26%26%25%25%26%24%26%24%26%26%25%
Net Profit290313311287328359361367366415376395429
EPS in Rs136.59147.27146.35135.09154.36168.76169.78172.73172.18195.43176.93185.86201.66
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

No reaction history yet.
No quarterly filings ingested yet.

Corporate actions

Last 6 months
KindValueEx-dateRecord
dividend
Dividend - Rs 525 Per Share & Special Dividend Rs 131 Per Share
525.0024 Jul '2624 Jul '26

Shareholding

as of Jun 2026
74.99%Promoter
Promoters74.99%
FIIs0.38%0.11
DIIs8.77%0.16
Public15.85%0.04
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
SUNPHARMA₹1,895.0035.994,54,6740.84%2,901+5.95%15,300+10.46%20.53%
DIVISLAB₹9,315.0083.002,47,2840.32%902+65.50%3,080+27.80%21.97%
TORNTPHARM₹4,914.0083.771,86,9130.77%566+5.79%4,921+54.85%15.19%
ZYDUSLIFE₹1,156.9023.701,15,4010.09%990−35.09%8,017+21.96%21.14%
CIPLA₹1,395.0031.491,12,6960.93%786−39.19%7,119+2.33%15.49%
LAURUSLABS₹1,876.7092.741,01,4000.11%362+125.49%2,026+29.10%17.76%
LUPIN₹2,105.0016.1796,2540.86%1,417+16.08%8,277+32.04%29.93%
ABBOTINDIA₹25,940.0034.1455,1232.02%429+17.13%1,814+4.33%44.80%
Median: 158 Co.₹426.1535.202,3030.08%13+30.25%164+18.67%14.96%

Filings

Annual reports15
Annual Report 2026bseAnnual Report 2025bseAnnual Report 2024bseAnnual Report 2023bseAnnual Report 2022bseAnnual Report 2021bseAnnual Report 2020bseAnnual Report 2019bseAnnual Report 2018bseAnnual Report 2017bseAnnual Report 2016bseAnnual Report 2015bseAnnual Report 2014bseAnnual Report 2012bseAnnual Report 2011bse
Concall transcripts3
TranscriptSep 2022RECSep 2022TranscriptJun 2021
Announcements5
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer 7 SepShareholder Meeting / Postal Ballot-Scrutinizer''s Report 14 AugAnnouncement under Regulation 30 (LODR)-Newspaper Publication 14 AugShareholder Meeting / Postal Ballot-Outcome of AGM 13 AugUnaudited Financial Results For The Quarter Ended June 30, 2026. 12 Aug